A recent study reveals that the use of guideline-directed medical therapy (GDMT) remains underutilized in post-heart failure patients, resulting in high rehospitalization rates and costs. Learn about the potential benefits of optimizing GDMT to enhance patient outcomes and reduce healthcare burdens.
Read MoreA 5-year follow-up study reveals the remarkable effectiveness of transcatheter edge-to-edge repair in treating secondary mitral regurgitation. Patients who underwent this minimally invasive procedure experienced lower rates of heart failure hospitalizations and improved survival compared to those receiving medical therapy alone.
Read MoreA qualitative study delves into the realm of cardiac palliative care programs, revealing their organizational structures, services, and encountered challenges. Learn how these programs address the unique needs of patients with advanced heart failure and guide the development of future initiatives.
Read MoreAnumana’s electrocardiogram (ECG) artificial intelligence (AI) algorithm, developed in collaboration with Mayo Clinic, has received FDA’s breakthrough device designation for early identification of cardiac amyloidosis.
Read MoreUnveiling the Potential: Angiotensin-Neprilysin Inhibition in Heart Failure In the realm of medical technology, breakthroughs often pave the way for innovative treatments that transform patient care. A recent randomized trial,...
Read More